Skip to main content
Watch Insiders
NSRX filings

Corporate insider profile

Dan Benjamin Teleman Filing Activity

Latest reported as Chief Executive Officer of Nasus Pharma Ltd (NSRX).

Purchase filings
2
Reported companies
1
Net open-market value
$31,209
Latest transaction
Jun 17, 2026

Affiliated corporations

Reported company relationships

NSRXLatest reported

Nasus Pharma Ltd

Chief Executive Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 17, 2026Nasus Pharma Ltd (NSRX)Chief Executive OfficerOpen Market Purchase6,550$3.10$20,305
Apr 22, 2026Nasus Pharma Ltd (NSRX)Chief Executive OfficerOpen Market Purchase2,900$3.76$10,904